CXCL12 and neoplasm: Moreover, tumor treatment with tranilast inhibits infiltration of TAMs by suppressing secretion of CXCL12, significantly promoting infiltration of CD8+ lymphocytes into the tumor and leading to apoptosis of cancer cells through an immune response (55).